Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
415 items
National Eye Institute logo.

Glaucoma and Marijuana Use

Glaucoma is an eye disease usually associated with an increased fluid pressure inside the eyes that damages the optic nerve, leading to vision loss or even blindness.
National Eye Institute logo.

Older Children Can Benefit From Treatment For Childhood's Most Common Eye Disorder

Surprising results from a nationwide clinical trial show that many children age seven through 17 with amblyopia (lazy eye) may benefit from treatments that are more commonly used on younger children.
National Eye Institute logo.

Gene Found to Increase Risk of the Most Common Cause of Blindness

Investigators have identified a gene that is “strongly associated” with a person’s risk for developing age-related macular degeneration (AMD).
capsules

Review Supports Vitamin E Dosage in AREDS

NEI researchers have concluded that taking a recommended 400 international units (IU) of vitamin E each day, as part of the AREDS formulation, does not increase the risk of death of persons at risk for advanced AMD.
National Eye Institute logo.

Eye Surgery on Histoplasmosis Lesions Provides Limited Benefits

For most patients with abnormal blood vessels in the eye, either as a delayed complication from a fungus infection called histoplasmosis or from unknown causes, surgery will not likely improve vision.
Fundus photograph of age-related macular degeneration showing drusen.

Vision Not Improved By Surgery for Complications of Age-Related Macular Degeneration

Vision does not improve substantially for patients with age-related macular degeneration (AMD) who undergo surgery to remove lesions of new blood vessels, scar tissue, or possible bleeding beneath the retina.
National Eye Institute logo.

Clinical Trial of Docosahexaenoic Acid in Patients with Retinitis Pigmentosa Receiving Vitamin A Treatment

Docosahexaenoic acid (DHA) supplementation at a dose of 1200 milligrams per day for four years did not, on average, slow the course of retinitis pigmentosa (RP) in adult RP patients already taking vitamin A supplements..
National Eye Institute logo.

Stem Cell Procedure Protects Mice from Degenerative Retinal Diseases; May Be Promising for People with Similar Retinal Diseases

An experimental 'rescue' of retinas by treating eyes with certain stem cells has been shown to preserve visual function in mice that were genetically predisposed to degenerative diseases of the retina.
National Eye Institute logo.

Los Latinos en los Estados Unidos Tienen Tasas Altas de Enfermedades de los Ojos y Deterioro Visual

Según un estudio de investigación, los latinos que residen en los Estados Unidos tienen tasas altas de enfermedades de los ojos y deterioro visual, y es posible que un número considerable de ellos no sepa que tiene una enfermedad de los ojos.
National Eye Institute logo.

U.S. Latinos Have High Rates of Eye Disease and Visual Impairment

Latinos living in the United States have high rates of eye disease and visual impairment, according to a research study, and a significant number may be unaware of their eye disease.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248